Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

MGM Is Out of New York Casino Competition. Here's Why it May Be Good for the Stock.

MGM Is Out of New York Casino Competition. Here's Why it May Be Good for the Stock.

Can Serve Robotics Expand Sidewalk Autonomy at Urban Scale in 2026?
Can Serve Robotics Expand Sidewalk Autonomy at Urban Scale in 2026?

Autonomous delivery is entering a new stage of expansion as advanced robotics intersect with increasing urban demand. Serve Robotics Inc. (SERV) is positioned in this shift as it works to build a

AXSM Up on FDA Priority Review to AXS-05 sNDA in Alzheimer's Agitation
AXSM Up on FDA Priority Review to AXS-05 sNDA in Alzheimer's Agitation

Shares of Axsome Therapeutics AXSM were up 22.8% on Dec. 31, after it announced that the FDA had accepted the supplemental new drug application (“sNDA”) seeking approval for AXS-05 (dextromethorphan

Helen of Troy Q3 Earnings on Deck: Key Factors You Should Understand
Helen of Troy Q3 Earnings on Deck: Key Factors You Should Understand

Helen of Troy Limited (HELE) is likely to register a decline in both top and bottom lines when it reports third-quarter fiscal 2026 earnings on Jan. 8. The Zacks Consensus Estimate for quarterly

Is it Wise to Hold Regency Centers Stock in Your Portfolio Now?
Is it Wise to Hold Regency Centers Stock in Your Portfolio Now?

Regency Centers Corp. REG stands to benefit from a well-located portfolio of high-quality shopping centers primarily situated in affluent suburbs and urban-adjacent trade areas with strong consumer

CMG's Throughput Push Accelerates: Can HEAP Reshape Store Economics?
CMG's Throughput Push Accelerates: Can HEAP Reshape Store Economics?

Chipotle Mexican Grill, Inc. CMG is sharpening its operational focus as it works to sustain transaction momentum in a more pressured consumer environment. A key area of emphasis is restaurant

IBM Gains 33% in a Year: Is it Worth Investing in the Stock Now?
IBM Gains 33% in a Year: Is it Worth Investing in the Stock Now?

International Business Machines Corporation IBM has surged 33% over the past year compared with the industry’s growth of 79.1%, driven by a strong demand for hybrid cloud and artificial intelligence

Can Intel Stock Replicate Its Stellar 2025 Performance This Year?
Can Intel Stock Replicate Its Stellar 2025 Performance This Year?

Despite a lackluster performance in the first half of 2025, Intel Corporation INTC stock hit a purple patch in the later stages of the year to script a remarkable turnaround. It gained 84.1% in 2025

Itron Down 26% in the Past 3 Months: What Should Investors Do Now?
Itron Down 26% in the Past 3 Months: What Should Investors Do Now?

Itron, Inc. ITRI shares have plunged 26% in the past three months, underperforming the Zacks Electronics - Testing Equipment industry’s growth of 4.7%. Also, it has underperformed the Zacks Computer

TransDigm to Buy Stellant Systems for $960M & Expand Product Portfolio
TransDigm to Buy Stellant Systems for $960M & Expand Product Portfolio

TransDigm Group, Inc. TDG recently revealed that it has inked an agreement to acquire Stellant Systems, Inc., a portfolio company of Arlington Capital Partners. The transaction is worth nearly $960

Is This the Right Time to Add PBH Stock to Your Portfolio?
Is This the Right Time to Add PBH Stock to Your Portfolio?

Prestige Consumer Healthcare PBH continues to experience robust momentum in the e-commerce channel due to its long-term investments and brand-specific digital strategies. Over the years, it has

Is it the Right Time to Add Insulet Stock to Your Portfolio?
Is it the Right Time to Add Insulet Stock to Your Portfolio?

Insulet PODD is well-poised to grow in the coming quarters due to the strength of its Omnipod 5 platform. The company is strongly executing against its long-term priorities to drive penetration

NKE Jumps 4.1% on Dec. 31 After CEO's $1 Million Insider Buy
NKE Jumps 4.1% on Dec. 31 After CEO's $1 Million Insider Buy

NIKE, Inc.’s NKE shares edged 4.1% higher on the last working day of 2025 after it was reported that its chief executive officer Elliott Hill purchased roughly $1 million worth of company shares in

Insights Into Albertsons Companies (ACI) Q3: Wall Street Projections for Key Metrics
Insights Into Albertsons Companies (ACI) Q3: Wall Street Projections for Key Metrics

Wall Street analysts forecast that Albertsons Companies, Inc. (ACI) will report quarterly earnings of $0.67 per share in its upcoming release, pointing to a year-over-year decline of 5.6%. It is

Will OSI (OSIS) Beat Estimates Again in Its Next Earnings Report?
Will OSI (OSIS) Beat Estimates Again in Its Next Earnings Report?

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering OSI Systems (OSIS), which belongs to the Zacks

Will Axos Financial (AX) Beat Estimates Again in Its Next Earnings Report?
Will Axos Financial (AX) Beat Estimates Again in Its Next Earnings Report?

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Axos Financial (AX), which belongs to the Zacks

Can K12 (LRN) Keep the Earnings Surprise Streak Alive?
Can K12 (LRN) Keep the Earnings Surprise Streak Alive?

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering K12 (LRN), which belongs to the Zacks Schools

All You Need to Know About Prenetics Global (PRE) Rating Upgrade to Buy
All You Need to Know About Prenetics Global (PRE) Rating Upgrade to Buy

Prenetics Global Limited (PRE) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Contineum Therapeutics, Inc. (CTNM) Upgraded to Buy: What Does It Mean for the Stock?
Contineum Therapeutics, Inc. (CTNM) Upgraded to Buy: What Does It Mean for the Stock?

Contineum Therapeutics, Inc. (CTNM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings

What Makes Steven Madden (SHOO) a New Strong Buy Stock
What Makes Steven Madden (SHOO) a New Strong Buy Stock

Investors might want to bet on Steven Madden (SHOO), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is